Homologous recombinational repair of DNA ensures mammalian chromosome stability

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 477, Issue 1-2, 2001, Pages 131-153

  Thompson, Larry H ^a   Schild, David ^b  

^a LAWRENCE LIVERMORE NATIONAL LABORATORY   (United States)

^b LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

Chromosome; DNA; Homologous recombinational repair

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; CELL EXTRACT; DOUBLE STRANDED DNA; RAD51 PROTEIN; RECOMBINANT DNA;

B LYMPHOCYTE; BREAST CANCER; CARCINOGENESIS; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL DIVISION; CHICKEN; CHROMOSOME BREAKAGE; DNA CROSS LINKING; DNA DAMAGE; DNA RECOMBINATION; DNA REPAIR; DNA STRAND BREAKAGE; EMBRYOPATHY; EXPERIMENTAL MOUSE; GENE ACTIVITY; GENE FUNCTION; GENE MUTATION; GENETIC ANALYSIS; GENETIC STABILITY; HUMAN; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN PURIFICATION; REVIEW;

ANIMALS; AVIAN PROTEINS; CHROMOSOMES; DNA REPAIR; DNA-BINDING PROTEINS; HUMANS; MAMMALS; NEOPLASMS; RAD51 RECOMBINASE; RECOMBINATION, GENETIC;

GALLUS GALLUS; MAMMALIA;

EID: 0035796042     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(01)00115-4     Document Type: Review

References (241)

1. Thompson L.H., Schild D. The contribution of homologous recombination in preserving genome integrity in mammalian cells. Biochimie. 81:1999;87-105.
2. Chu G. Double strand break repair. J. Biol. Chem. 272:1997;24097-24100.
3. Petrini J.H.J., Bressan D.A., Yao M.S. The RAD52 epistatsis group in mammalian double strand break repair. Seminars Immunol. 9:1997;181-188.
4. Petrini J.H. The mammalian Mre11-Rad50-nbs1 protein complex: integration of functions in the cellular DNA-damage response. Am. J. Hum. Genet. 64:1999;1264-1269.
5. Jeggo P.A. DNA breakage and repair. Adv. Genet. 38:1998;185-218.
6. Jeggo P.A. Identification of genes involved in repair of DNA double-strand breaks in mammalian cells. Radiat. Res. 150:1998;S80-S91.
7. Kanaar R., Hoeijmakers J.H., van Gent D.C. Molecular mechanisms of DNA double strand break repair. Trends Cell Biol. 8:1998;483-489.
8. Dasika G.K., Lin S.C., Zhao S., Sung P., Tomkinson A., Lee E.Y. DNA damage-induced cell cycle checkpoints and DNA strand break repair in development and tumorigenesis. Oncogene. 18:1999;7883-7899.
9. Pastink A., Lohman P.H. Repair and consequences of double-strand breaks in DNA. Mutat. Res. 428:1999;141-156.
10. Thacker J. A surfeit of RAD51-like genes? Trends Genet. 15:1999;166-168.
11. Thacker J. The role of homologous recombination processes in the repair of severe forms of DNA damage in mammalian cells. Biochimie. 81:1999;77-85.
12. Jasin M. Chromosome breaks and genomic instability. Cancer Invest. 18:2000;78-86.
13. Morrison C., Takeda S. Genetic analysis of homologous DNA recombination in vertebrate somatic cells. Int. J. Biochem. Cell Biol. 32:2000;817-831.
14. Paques F., Haber J.E. Multiple pathways of recombination induced by double-strand breaks in Saccharomyces cerevisiae. Microbiol. Mol. Biol. Rev. 63:1999;349-404.
15. Haber J.E. DNA recombination: the replication connection. Trends Biochem. Sci. 24:1999;271-275.
16. Takata M., Sasaki M.S., Sonoda E., Morrison C., Hashimoto M., Utsumi H., Yamaguchi-Iwai Y., Shinohara A., Takeda S. Homologous recombination and nonhomologous end joining pathways of DNA double-strand break repair have overlapping roles in the maintenance of chromosomal integrity in vertebrate cells. EMBO J. 17:1998;5497-5508.
17. Liang F., Han M., Romaniekno P.J., Jasin M. Homology-directed repair is a major double-strand break repair pathway in mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 95:1998;5172-5177.
18. Lin Y., Lukacsovich T., Waldman A.S. Multiple pathways for repair of DNA double-strand breaks in mammalian chromosomes. Mol. Cell. Biol. 19:1999;8353-8360.
19. Jeggo P.A. DNA-PK: at the cross-roads of biochemistry and genetics. Mutat. Res. 384:1997;1-14.
20. Liu N., Lamerdin J.E., Tebbs R.S., Schild D., Tucker J.D., Shen M.R., Brookman K.W., Siciliano M.J., Walter C.A., Fan W., Narayana L.S., Zhou Z.Q., Adamson A.W., Sorensen K.J., Chen D.J., Jones N.J., Thompson L.H. XRCC2 and XRCC3, new human Rad51-family members, promote chromosome stability and protect against DNA crosslinks and other damages. Mol. Cell. 1:1998;783-793.
21. Cartwright R., Tambini C.E., Simpson P.J., Thacker J. The XRCC2 DNA repair gene from human and mouse encodes a novel member of the recA/Rad51 family. Nucl. Acids Res. 26:1998;3084-3089.
22. Cui X., Brenneman M., Meyne J., Oshimura M., Goodwin E.H., Chen D.J. The XRCC2 and XRCC3 repair genes are required for chromosome stability in mammalian cells. Mutat. Res. 434:1999;75-88.
23. Pierce A.J., Johnson R.D., Thompson L.H., Jasin M. XRCC3 promotes homology-directed repair of DNA damage in mammalian cells. Genes Devlop. 13:1999;2633-2638.
24. Johnson R.D., Liu N., Jasin M. Mammalian XRCC2 promotes the repair of DNA double-strand breaks by homologous recombination. Nature. 401:1999;397-399.
25. Sonoda E., Sasaki M., Buerstedde J.M., Bezzubova O., Shinohara A., Ogazwa H., Takata M., Yamaguchi-Iwai Y., Takeda S. Rad51 deficient vertebrate cells accumulate chromosomal breaks prior to cell death. EMBO J. 17:1998;598-608.
26. Tsuzuki T., Fujii Y., Sakumi K., Tominaga Y., Nakao K., Sekiguchi M., Matsushiro A., Yoshimura Y., Morita T. Targeted disruption of the Rad51 gene leads to lethality in embryonic mice. Proc. Natl. Acad. Sci. U.S.A. 93:1996;6236-6240.
27. Lim D.S., Hasty P. A mutation in mouse Rad51 results in an early embryonic lethal that is suppressed by a mutation in p53. Mol. Cell. Biol. 16:1996;7133-7143.
28. Kemp L.M., Jeggo P.A. Radiation-induced chromosome damage in X-ray-sensitive mutants (xrs) of the Chinese hamster ovary cell line. Mutat. Res. 166:1986;255-263.
29. Karanjawala Z.E., Grawunder U., Hsieh C.L., Lieber M.R. The nonhomologous DNA end joining pathway is important for chromosome stability in primary fibroblasts. Curr. Biol. 9:1999;1501-1504.
30. Difilippantonio M.J., Zhu J., Chen H.T., Meffre E., Nussenzweig M.C., Max E.E., Ried T., Nussenzweig A. DNA repair protein Ku80 suppresses chromosomal aberrations and malignant transformation. Nature. 404:2000;510-514.
31. Gao Y., Ferguson D.O., Xie W., Manis J.P., Sekiguchi J., Frank K.M., Chaudhuri J., Horner J., DePinho R.A., Alt F.W. Interplay of p53 and DNA-repair protein XRCC4 in tumorigenesis genomic, stability and development. Nature. 404:2000;897-900.
32. Li G.C., Ouyang H., Li X., Nagasawa H., Little J.B., Chen D.J., Ling C.C., Fuks Z., Cordon-Cardo C. Ku70: a candidate tumor suppresser gene for murine T cell lymphoma. Mol. Cell. 2:1998;1-8.
33. Wang P., Zhou R.H., Zou Y., Jackson-Cook C.K., Povirk L.F. Highly conservative reciprocal translocations formed by apparent joining of exchanged DNA double-strand break ends. Proc. Natl. Acad. Sci. U.S.A. 94:1997;12018-12023.
34. Haber J.E. Partners and pathways repairing a double-strand break. Trends Genet. 16:2000;259-264.
35. M. Jasin, LOH and mitotic recombination, in: M. Ehrlich (Ed.), DNA Alterations in Cancer: Genetic and Epigenetic Changes, Eaton Publishing, Natick, MA, 2000, pp. 191-209.
36. Painter R.B. A replication model for sister-chromatid exchange. Mutat. Res. 70:1980;337-341.
37. Sonoda E., Sasaki M.S., Morrison C., Yamaguchi-Iwai Y., Takata M., Takeda S. Sister chromatid exchanges are mediated by homologous recombination in vertebrate cells. Mol. Cell. Biol. 19:1999;5166-5169.
38. Dronkert M.L., Beverloo H.B., Johnson R.D., Hoeijmakers J.H., Jasin M., Kanaar R. Mouse RAD54 affects DNA double-strand break repair and sister chromatid exchange. Mol. Cell. Biol. 20:2000;3147-3156.
39. Johnson R.D., Jasin M. Sister chromatid gene conversion is a prominent double-strand break repair pathway in mammalian cells. EMBO J. 19:2000;3398-3407.
40. A.V. Carrano, L.H. Thompson, Sister chromatid exchange, DNA repair, and single-gene mutation, in: C.C. Harris, P.A. Cerutti (Eds.), Mechanisms of Chemical Carcinogenesis, Liss, New York, 1982, pp. 441-447.
41. Morgan W.F., Chung H.W., Phillips J.W., Winegar R.A. Restriction endonucleases do not induce sister-chromatid exchanges in Chinese hamster ovary cells. Mutat. Res. 226:1989;203-209.
42. Folle G.A., Johannes C., Mechoso B.H., Medina I.I., Obe G. The restriction endonuclease AluI induces sister chromatid exchange in Chinese hamster ovary cells. Mutagenesis. 7:1992;291-294.
43. Takata M., Sasaki M.S., Sonoda E., Fukushima T., Morrison C., Albala J.S., Swagemakers S.M., Kanaar R., Thompson L.H., Takeda S. The rad51 paralog Rad51B promotes homologous recombinational repair. Mol. Cell. Biol. 20:2000;6476-6482.
44. Takata M., Sasaki M.S., Tachiiri S., Fukushima T., Sonoda E., Schild D., Thompson L.H., Takeda S. Chromosome instability and defective recombinational repair in knockout mutants of the five Rad51 paralogs. Mol. Cell. Biol. 21:2001;1853-2866.
45. Brenneman M.A., Weiss A.E., Nickoloff J.A., Chen D.J. XRCC3 is required for efficient repair of chromosome breaks by homologous recombination. Mutat. Res. 459:2000;89-97.
46. Griffin C.S., Simpson P.J., Wilson C.R., Thacker J. Mammalian recombination-repair genes XRCC2 and XRCC3 promote correct chromosome segregation. Nat. Cell. Biol. 2:2000;757-761.
47. Essers J., van Steeg H., de Wit J., Swagemakers S.M., Vermeij M., Hoeijmakers J.H., Kanaar R. Homologous and non-homologous recombination differentially affect DNA damage repair in mice. EMBO J. 19:2000;1703-1710.
48. Friedberg E.C., Meira L.B. Database of mouse strains carrying targeted mutations in genes affecting cellular responses to DNA damage, Version 4. Mutat. Res. 459:2000;243-274.
49. Luo G., Yao M.S., Bender C.F., Mills M., Bladl A.R., Bradley A., Petrini J.H. Disruption of mRad50 causes embryonic stem cell lethality, abnormal embryonic development, and sensitivity to ionizing radiation. Proc. Natl. Acad. Sci. U.S.A. 96:1999;7376-7381.
50. Shu Z., Smith S., Wang L., Rice M.C., Kmiec E.B. Disruption of muREC2/RAD51L1 in mice results in early embryonic lethality which can be partially rescued in a p53(-/-) background. Mol. Cell. Biol. 19:1999;8686-8693.
51. Pittman D.L., Schimenti J.C. Midgestation lethality in mice deficient for the Rec-Arelated gene Rad51d/Rad51l3. Genesis. 26:2000;167-173.
52. Ludwig T., Chapman D.L., Papaioannou V.E., Efstratiadis A. Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2 Brca1/p53 and Brca2/p53 nullizygous embryos. Genes Devlop. 11:1997;1226-1241.
53. Gowen L.C., Avrutskaya A.V., Latour A.M., Koller B.H., Leadon S.A. BRCA1 required for transcription-coupled repair of oxidative DNA damage. Science. 281:1998;1009-1012.
54. Shen S.X., Weaver Z., Xu X., Li C., Weinstein M., Chen L., Guan X.Y., Ried T., Deng C.X. A targeted disruption of the murine Brca1 gene causes gamma-irradiation hypersensitivity and genetic instability. Oncogene. 17:1998;3115-3124.
55. Connor F., Bertwistle D., Mee P.J., Ross G.M., Swift S., Grigorieva E., Tybulewicz V.L., Ashworth A. Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation. Nat. Genet. 17:1997;423-430.
56. Morimatsu M., Donoho G., Hasty P. Cells deleted for Brca2 COOH terminus exhibit hypersensitivity to gamma-radiation and premature senescence. Cancer Res. 58:1998;3441-3447.
57. Abbott D.W., Freeman M.L., Holt J.T. Double-strand break repair deficiency and radiation sensitivity in BRCA2 mutant cancer cells. J. Natl. Cancer Inst. 90:1998;978-985.
58. Scully R., Ganesan S., Vlasakova K., Chen J., Socolovsky M., Livingston D.M. Genetic analysis of BRCA1 function in a defined tumor cell line. Mol. Cell. 4:1999;1093-1099.
59. Abbott D.W., Thompson M.E., Robinson-Benion C., Tomlinson G., Jensen R.A., Holt J.T. BRCA1 expression restores radiation resistance in BRCA1-defective cancer cells through enhancement of transcription-coupled DNA repair. J. Biol. Chem. 274:1999;18808-18812.
60. Patel K.J., Yu V.P., Lee H., Corcoran A., Thistlethwaite F.C., Evans M.J., Colledge W.H., Friedman L.S., Ponder B.A., Venkitaraman A.R. Involvement of Brca2 in DNA repair. Mol. Cell. 1:1998;347-357.
61. Xu X., Weaver Z., Linke S.P., Li C., Gotay J., Wang X.W., Harris C.C., Ried T., Deng C.X. Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells. Mol. Cell. 3:1999;389-395.
62. Tutt A., Gabriel A., Bertwistle D., Connor F., Paterson H., Peacock J., Ross G., Ashworth A. Absence of brca2 causes genome instability by chromosome breakage and loss associated with centrosome amplification. Curr. Biol. 9:1999;1107-1110.
63. Chen C.F., Chen P.L., Zhong Q., Sharp Z.D., Lee W.H. Expression of BRC repeats in breast cancer cells disrupts the BRCA2-Rad51 complex and leads to radiation hypersensitivity and loss of G(2)/M checkpoint control. J. Biol. Chem. 274:1999;32931-32935.
64. Moynahan M.E., Chiu J.W., Koller B.H., Jasin M. Brca1 controls homology-directed DNA repair. Mol. Cell. 4:1999;511-518.
65. Snouwaert J.N., Gowen L.C., Latour A.M., Mohn A.R., Xiao A., DiBiase L., Koller B.H. BRCA1 deficient embryonic stem cells display a decreased homologous recombination frequency and an increased frequency of non-homologous recombination that is corrected by expression of a brca1 transgene. Oncogene. 18:1999;7900-7907.
66. Cressman V.L., Backlund D.C., Avrutskaya A.V., Leadon S.A., Godfrey V., Koller B.H. Growth retardation, DNA repair defects, and lack of spermatogenesis in BRCA1-deficient mice. Mol. Cell. Biol. 19:1999;7061-7075.
67. Baumann P., West S.C. Role of the human RAD51 protein in homologous recombination and double-strand break repair. TIBS. 23:1998;247-251.
68. Bianco P.R., Tracy R.B., Kowalczykowski S.C. DNA strand exchange proteins: a biochemical and physical comparison. Front. Biosci. 3:1998;D570-603.
69. Shinohara A., Ogawa T. Rad51/RecA protein families and the associated proteins in eukaryotes. Mutat. Res. 435:1999;13-21.
70. Morrison C., Shinohara A., Sonoda E., Yamaguchi-Iwai Y., Takata M., Weichselbaum R.R., Takeda S. The essential functions of human rad51 are independent of ATP hydrolysis. Mol. Cell. Biol. 19:1999;6891-6897.
71. De Zutter J.K., Knight K.L. The hRad51 and RecA proteins show significant differences in cooperative binding to single-stranded DNA. J. Mol. Biol. 293:1999;769-780.
72. 2+ induces a conformational change in Rad51. Biochemistry. 37:1998;11932-11939.
73. Zaitseva E.M., Zaitsev E.N., Kowalczykowski S.C. The DNA binding properties of Saccharomyces cerevisiae Rad51 protein. J. Biol. Chem. 274:1999;2907-2915.
74. Gupta R.C., Folta-Stogniew E., Radding C.M. Human Rad51 protein can form homologous joints in the absence of net strand exchange. J. Biol. Chem. 274:1999;1248-1256.
75. Baumann P., West S.C. Heteroduplex formation by human Rad51 protein: effects of DNA end-structure, hRP-A and hRad52. J. Mol. Biol. 291:1999;363-374.
76. Golub E.I., Gupta R.C., Haaf T., Wold M.S., Radding C.M. Interaction of human rad51 recombination protein with single-stranded DNA binding protein, RPA. Nucl. Acids Res. 26:1998;5388-5393.
77. Aihara H., Ito Y., Kurumizaka H., Yokoyama S., Shibata T. The N-terminal domain of the human Rad51 protein binds DNA: structure and a DNA binding surface as revealed by NMR. J. Mol. Biol. 290:1999;495-504.
78. Yuan Z.M., Huang Y., Ishiko T., Nakada S., Utsugisawa T., Kharbanda S., Wang R., Sung P., Shinohara A., Weichselbaum R., Kufe D. Regulation of Rad51 function by c-Abl in response to DNA damage. J. Biol. Chem. 272:1998;3799-3802.
79. Kurumizaka H., Aihara H., Kagawa W., Shibata T., Yokoyama S. Human Rad51 amino acid residues required for Rad52 binding. J. Mol. Biol. 291:1999;537-548.
80. Donovan J.W., Milne G.T., Weaver D.T. Homotypic and heterotypic protein associations control Rad51 function in double-strand break repair. Genes Devlop. 8:1994;2552-2562.
81. Mazin A.V., Zaitseva E., Sung P., Kowalczykowski S.C. Tailed duplex DNA is the preferred substrate for rad51 protein-mediated homologous pairing. EMBO J. 19:2000;1148-1156.
82. Krejci L., Thomsen L.K., Duno M., Westergaard O., Bendixen C. Homomeric interaction of the mouse Rad52 protein. Mol. Biol. Rep. 27:2000;55-59.
83. Van Dyck E., Hajibagheri N.M., Stasiak A., West S.C. Visualisation of human rad52 protein and its complexes with hRad51 and DNA. J. Mol. Biol. 284:1998;1027-1038.
84. Stasiak A.Z., Larquet E., Stasiak A., Muller S., Engel A., Van Dyck E., West S.C., Egelman E.H. The human Rad52 protein exists as a heptameric ring. Curr. Biol. 10:2000;337-340.
85. Shinohara A., Shinohara M., Ohta T., Matsuda S., Ogawa T. Rad52 forms ring structures and co-operates with RPA in single-strand DNA annealing. Genes Cells. 3:1998;145-156.
86. E. Van Dyck, A.Z. Stasiak, A. Stasiak, S.C. West, Binding of double-strand breaks in DNA by human Rad52 protein, Nature 398 (1999) 728-731 (published erratum appears in Nature 401 (6751) (1999) 403).
87. E. Van Dyck, A.Z. Stasiak, A. Stasiak, S.C. West, Binding of double-strand breaks in DNA by human Rad52 protein, Nature 398 (1999) 728-731 (published erratum appears in Nature 401 (6751) (1999) 403).
88. Hiom K. Rad52-the means to an end. Curr. Biol. 9:1999;R446-R448.
89. Parsons C.A., Baumann P., Van Dyck E., West S.C. Precise binding of single-stranded DNA termini by human rad52 protein. EMBO J. 19:2000;4175-4181.
90. Swagemakers S.M.A., Essers J., de Wit J., Hoeijmakers J.H.J., Kanaar R. The human rad54 recombinational DNA repair protein is a double-stranded DNA-dependent ATPase. J. Biol. Chem. 273:1998;28292-28297.
91. Tan T.L., Essers J., Citterio E., Swagemakers S.M., de Wit J., Benson F.E., Hoeijmakers J.H., Kanaar R. Mouse Rad54 affects DNA conformation and DNA-damage-induced Rad51 foci formation. Curr. Biol. 9:1999;325-328.
92. Petukhova G., Van Komen S., Vergano S., Klein H., Sung P. Yeast Rad54 promotes Rad51-dependent homologous DNA pairing via ATP hydrolysis-driven change in DNA double helix conformation. J. Biol. Chem. 274:1999;29453-29462.
93. Hiramoto T., Nakanishi T., Sumiyoshi T., Fukuda T., Matsuura S., Tauchi H., Komatsu K., Shibasaki Y., Inui H., Watatani M., Yasutomi M., Sumii K., Kajiyama G., Kamada N., Miyagawa K., Kamiya K. Mutations of a novel human RAD54 homologue, RAD54B, in primary cancer. Oncogene. 18:1999;3422-3426.
94. Tanaka K., Hiramoto T., Fukuda T., Miyagawa K. A Novel human Rad54 homologue, Rad54B, associates with Rad51. J. Biol. Chem. 275:2000;26316-26321.
95. Sung P. Yeast Rad55 and Rad57 proteins form a heterodimer that functions with RPA to promote DNA strand exchange by Rad51 recombinase. Genes Devlop. 11:1997;1111-1121.
96. Braybrooke J.P., Spink K.G., Thacker J., Hickson I.D. The RAD51 family member, RAD51L3, is a DNA-stimulated ATPase that forms a complex with XRCC2. J. Biol. Chem. 275:2000;29100-29106.
97. Schild D., Lio Y.C., Collins D.W., Tsomondo T., Chen D.J. Evidence for simultaneous protein interactions between human Rad51 paralogs. J. Biol. Chem. 275:2000;16443-16449.
98. Havre P.A., Rice M., Ramos R., Kmiec E.B. HsRec2/Rad51L1, a protein influencing cell cycle progression, has protein kinase activity. Exp. Cell Res. 254:2000;33-44.
99. Bressan D.A., Baxter B.K., Petrini J.H. The Mre11-Rad50-Xrs2 protein complex facilitates homologous recombination-based double-strand break repair in Saccharomyces cerevisiae. Mol. Cell. Biol. 19:1999;7681-7687.
100. Weemaes C.M., Smeets D.F., van der Burgt C.J. Nijmegen Breakage syndrome: a progress report. Int. J. Radiat. Biol. 66:1994;S185-188.
101. Usui T., Ohta T., Oshiumi H., Tomizawa J., Ogawa H., Ogawa T. Complex formation and functional versatility of Mre11 of budding yeast in recombination. Cell. 95:1998;705-716.
102. Xiao Y., Weaver D.T. Conditional gene targeted deletion by Cre recombinase demonstrates the requirement for the double-strand break repair Mre11 protein in murine embryonic stem cells. Nucl. Acids Res. 25:1997;2985-2991.
103. Yamaguchi-Iwai Y., Sonoda E., Sasaki M.S., Morrison C., Haraguchi T., Hiraoka Y., Yamashita Y.M., Yagi T., Takata M., Price C., Kakazu N., Takeda S. Mre11 is essential for the maintenance of chromosomal DNA in vertebrate cells. EMBO J. 18:1999;6619-6629.
104. Paull T.T., Gellert M. Nbs1 potentiates ATP-driven DNA unwinding and endonuclease cleavage by the Mre11/Rad50 complex. Genes Devlop. 13:1999;1276-1288.
105. Goedecke W., Eijpe M., Offenberg H.H., Aalderen M.V., Heyting C. Mre11 and Ku70 interact in somatic cells, but are differentially expressed in early meiosis. Nat. Genet. 23:1999;194-198.
106. Raderschall E., Golub E.I., Haaf T. Nuclear foci of mammalian recombination proteins are located at single-stranded DNA regions formed after DNA damage. Proc. Natl. Acad. Sci. U.S.A. 96:1999;1921-1926.
107. Tashiro S., Walter J., Shinohara A., Kamada N., Cremer T. Rad51 accumulation at sites of DNA damage and in postreplicative chromatin. J. Cell. Biol. 150:2000;283-291.
108. Haaf T., Raderschall E., Reddy G., Ward D.C., Radding C.M., Golub E.I. Sequestration of mammalian Rad51-recombination protein into micronuclei. J. Cell. Biol. 144:1999;11-20.
109. Strike P., Jones N.J. Mechanisms of genome maintenance and rearrangement: current research and recent advances in DNA repair and recombination. Mutat. Res. 435:1999;163-169.
110. Liu Y., Li M.j., Lee E.Y., Maizels N. Localization and dynamic relocalization of mammalian Rad52 during the cell cycle and in response to DNA damage. Curr. Biol. 9:1999;975-978.
111. Paull T.T., Rogakou E.P., Yamazaki V., Kirchgessner C.U., Gellert M., Bonner W.M. A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr. Biol. 10:2000;886-895.
112. Chen J., Silver D.P., Walpita D., Cantor S.B., Gazdar A.F., Tomlinson G., Couch F.J., Weber B.L., Ashley T., Livingston D.M., Scully R. Stable interaction between the products of the BRCA1 and BRCA2 tumor suppresser genes in mitotic and meiotic cells. Mol. Cell. 2:1998;317-328.
113. Chen J.J., Silver D., Cantor S., Livingston D.M., Scully R. BRCA1, BRCA2, and Rad51 operate in a common DNA damage response pathway. Cancer Res. 59:1999;1752s-1756s.
114. Yuan S.S., Lee S.Y., Chen G., Song M., Tomlinson G.E., Lee E.Y. BRCA2 is required for ionizing radiation-induced assembly of Rad51 complex in vivo. Cancer Res. 59:1999;3547-3551.
115. Bhattacharyya A., Ear U.S., Koller B.H., Weichselbaum R.R., Bishop D.K. The breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of Rad51 and survival following treatment with the DNA cross-linking agent cisplatin. J. Biol. Chem. 275:2000;23899-23903.
116. Bishop D.K., Ear U., Bhattacharyya A., Calderone C., Beckett M., Weichselbaum R.R., Shinohara A. XRCC3 is required for assembly of Rad51 complexes in vivo. J. Biol. Chem. 273:1998;21482-21488.
117. M. Kraakman-van der Zwet, W.J. Overkamp, R.T. Tan, R.E. van Lange, R. Kanaar, M.Z. Zdzienicka, The XRCC11 gene is required for assembly of Rad51 complexes, in: Proceedings of the ASM Conference on DNA Repair and Mutagenesis, Hilton Head, SC, 1-7 November 1999, p. 142.
118. Karow J.K., Chakraverty R.K., Hickson I.D. The Bloom's syndrome gene product is a 3′-5′ DNA helicase. J. Biol. Chem. 272:1997;30611-30614.
119. Neff N.F., Ellis N.A., Ye T.Z., Noonan J., Huang K., Sanz M., Proytcheva M. The DNA helicase activity of BLM is necessary for the correction of the genomic instability of bloom syndrome cells. Mol. Biol. Cell. 10:1999;665-676.
120. Moens P.B., Freire R., Tarsounas M., Spyropoulos B., Jackson S.P. Expression and nuclear localization of BLM, a chromosome stability protein mutated in Bloom's syndrome, suggest a role in recombination during meiotic prophase. J. Cell Sci. 113:2000;663-672.
121. Ishov A.M., Sotnikov A.G., Negorev D., Vladimirova O.V., Neff N., Kamitani T., Yeh E.T., Strauss 3rd J.F., Maul G.G. PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1. J. Cell Biol. 147:1999;221-234.
122. Zhong S., Hu P., Ye T.Z., Stan R., Ellis N.A., Pandolfi P.P. A role for PML and the nuclear body in genomic stability. Oncogene. 18:1999;7941-7947.
123. O. Bischof, S.H. Kim, J. Irving, S. Beresten, N.A. Ellis, J. Campisi, Regulation and localization of the Bloom syndrome protein in response to DNA damage, J. Cell Biol., 2001, in press.
124. Lombard D.B., Guarente L. Nijmegen breakage syndrome disease protein and MRE11 at PML nuclear bodies and meiotic telomeres. Cancer Res. 60:2000;2331-2334.
125. Dong Z., Zhong Q., Chen P.L. The Nijmegen breakage syndrome protein is essential for Mre11 phosphorylation upon DNA damage. J. Biol. Chem. 274:1999;19513-19516.
126. Zhong Q., Chen C.F., Li S., Chen Y., Wang C.C., Xiao J., Chen P.L., Sharp Z.D., Lee W.H. Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response. Science. 285:1999;747-750.
127. Wang Y., Cortez D., Yazdi P., Neff N., Elledge S.J., Qin J. BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Devlop. 14:2000;927-939.
128. Cortez D., Wang Y., Qin J., Elledge S.J. Requirement of ATM-dependent phosphorylation of Brca1 in the DNA damage response to double-strand breaks. Science. 286:1999;1162-1166.
129. Maser R.S., Monsen K.J., Nelms B.E., Petrini J.H.J. hMre11 and hRad50 nuclear foci are induced during the normal cellular response to DNA double-strand breaks. Mol. Cell. Biol. 17:1997;6097-6104.
130. Morrison C., Sonoda E., Takao N., Shinohara A., Yamamoto K.I., Takeda S. The controlling role of ATM in homologous recombinational repair of DNA damage. EMBO J. 19:2000;463-471.
131. Lee J.S., Collins K.M., Brown A.L., Lee C.H., Chung J.H. hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response. Nature. 404:2000;201-204.
132. Hartwell L.H., Weinert T.A. Checkpoints: controls that ensure the order of cell cycle events. Science. 246:1989;629-634.
133. O'Connor P.M. Mammalian G1 and G2 phase checkpoints. Cancer Surv. 29:1997;151-182.
134. Pandita T.K., Lieberman H.B., Lim D.S., Dhar S., Zheng W., Taya Y., Kastan M.B. Ionizing radiation activates the ATM kinase throughout the cell cycle. Oncogene. 19:2000;1386-1391.
135. Rotman G., Shiloh Y. Ataxia-telangiectasia: is ATM a sensor of oxidative damage and stress? Bioessays. 19:1997;911-917.
136. Rotman G., Shiloh Y. ATM: from gene to function. Hum. Mol. Genet. 7:1998;1555-1563.
137. Banin S., Moyal L., Shieh S., Taya Y., Anderson C.W., Chessa L., Smorodinsky N.I., Prives C., Reiss Y., Shiloh Y., Ziv Y. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science. 281:1998;1674-1677.
138. Lavin M.F., Concannon P., Gatti R.A. Eighth International Workshop on Ataxia-Telangiectasia (ATW8). Cancer Res. 59:1999;3845-3849.
139. Lavin M.F., Khanna K.K. ATM: the protein encoded by the gene mutated in the radiosensitive syndrome ataxia-telangiectasia. Int. J. Radiat. Biol. 75:1999;1201-1214.
140. Suzuki K., Kodama S., Watanabe M. Recruitment of ATM protein to double strand DNA irradiated with ionizing radiation. J. Biol. Chem. 274:1999;25571-25575.
141. Smith G.C., Cary R.B., Lakin N.D., Hann B.C., Teo S.H., Chen D.J., Jackson S.P. Purification and DNA binding properties of the ataxia-telangiectasia gene product ATM. Proc. Natl. Acad. Sci. U.S.A. 96:1999;11134-11139.
142. Khanna K.K., Beamish H., Yan J., Hobson K., Williams R., Dunn I., Lavin M.F. Nature of G1/S cell cycle checkpoint defect in ataxia-telangiectasia. Oncogene. 11:1995;609-618.
143. Beamish H., Williams R., Chen P., Lavin M.F. Defect in multiple cell cycle checkpoints in ataxia-telangiectasia postirradiation. J. Biol. Chem. 271:1996;20486-20493.
144. Lakin N.D., Jackson S.P. Regulation of p53 in response to DNA damage. Oncogene. 18:1999;7644-7655.
145. Carney J.P., Maser R.S., Olivares H., Davis E.M., Le Beau M., Yates J.R., Hays L., Morgan W.F., Petrini J.H. The hMre11/hRad50 protein complex and Nijmegen breakage syndrome: linkage of double-strand break repair to the cellular DNA damage response. Cell. 93:1998;477-486.
146. Nelms B.E., Maser R.S., MacKay J.F., Lagally M.G., Petrini J.H.J. In situ visualization of DNA double-strand break repair in human fibroblasts. Science. 280:1998;590-592.
147. Jongmans W., Vuillaume M., Chrzanowska K., Smeets D., Sperling K., Hall J. Nijmegen breakage syndrome cells fail to induce the p53-mediated DNA damage response following exposure to ionizing radiation. Mol. Cell. Biol. 17:1997;5016-5022.
148. Yamazaki V., Wegner R.D., Kirchgessner C.U. Characterization of cell cycle checkpoint responses after ionizing radiation in Nijmegen breakage syndrome cells. Cancer Res. 58:1998;2316-2322.
149. Antoccia A., Stumm M., Saar K., Ricordy R., Maraschio P., Tanzarella C. Impaired p53-mediated DNA damage response, cell-cycle disturbance and chromosome aberrations in Nijmegen breakage syndrome lymphoblastoid cell lines. Int. J. Radiat. Biol. 75:1999;583-591.
150. Matsuura K., Balmukhanov T., Tauchi H., Weemaes C., Smeets D., Chrzanowska K., Endou S., Matsuura S., Komatsu K. Radiation induction of p53 in cells from Nijmegen breakage syndrome is defective but not similar to ataxia-telangiectasia. Biochem. Biophys. Res. Commun. 242:1998;602-607.
151. J. German, The chromosome-breakage syndromes: rare disorders that provide models for studying somatic mutation, in: L. Spatz, A.D. Bloom, N.W. Paul (Eds.), Detection of Cancer Predisposition: Laboratory Approaches, March of Dimes Birth Defects Foundation, White Plains, NY, 1990, pp. 85-111.
152. Elson A., Wang Y., Daugherty C.J., Morton C.C., Zhou F., Campos-Torres J., Leder P. Pleiotropic defects in ataxia-telangiectasia protein-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 93:1996;13084-13089.
153. Lehmann A.R., Stevens S. The response of ataxia telangiectasia cells to bleomycin. Nucl. Acids Res. 6:1979;1953-1960.
154. Cornforth M.N., Bedford J.S. On the nature of a defect in cells from individuals with ataxia-telangiectasia. Science. 227:1985;1589-1591.
155. 241Am alpha-particles or bleomycin Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 51:1987;209-218.
156. Blocher D., Sigut D., Hannan M.A. Fibroblasts from ataxia telangiectasia (AT) and AT heterozygotes show an enhanced level of residual DNA double-strand breaks after low dose-rate gamma-irradiation as assayed by pulsed field gel electrophoresis. Int. J. Radiat. Biol. 60:1991;791-802.
157. Foray N., Priestley A., Alsbeih G., Badie C., Capulas E.P., Arlett C.F., Malaise E.P. Hypersensitivity of ataxia telangiectasia fibroblasts to ionizing radiation is associated with a repair deficiency of DNA double-strand breaks. Int. J. Radiat. Biol. 72:1997;271-283.
158. Meyn M.S. High spontaneous intrachromosomal recombination rates in ataxia-telangiectasia. Science. 260:1993;1327-1330.
159. Luo C.M., Tang W., Mekeel K.L., DeFrank J.S., Anne P.R., Powell S.N. High frequency and error-prone DNA recombination in ataxia telangiectasia cell lines. J. Biol. Chem. 271:1996;4497-4503.
160. Bishop A.J., Barlow C., Wynshaw-Boris A.J., Schiestl R.H. Atm deficiency causes an increased frequency of intrachromosomal homologous recombination in mice. Cancer Res. 60:2000;395-399.
161. E.T. Hojo, P.C. van Diemen, F. Darroudi, A.T. Natarajan, Spontaneous chromosomal aberrations in Fanconi anaemia, ataxia telangiectasia fibroblast and Bloom's syndrome lymphoblastoid cell lines as detected by conventional cytogenetic analysis and fluorescence in situ hybridisation (FISH) technique, Mutat. Res. 334 (1995) 59-69 (published erratum appears in Mutat. Res. 334 (1995) 268-270).
162. E.T. Hojo, P.C. van Diemen, F. Darroudi, A.T. Natarajan, Spontaneous chromosomal aberrations in Fanconi anaemia, ataxia telangiectasia fibroblast and Bloom's syndrome lymphoblastoid cell lines as detected by conventional cytogenetic analysis and fluorescence in situ hybridisation (FISH) technique, Mutat. Res. 334 (1995) 59-69 (published erratum appears in Mutat. Res. 334 (1995) 268-270).
163. Kohn P.H., Whang-Peng J., Levis W.R. Chromosomal instability in ataxia telangiectasia. Cancer Genet. Cytogenet. 6:1982;289-302.
164. Kim S.T., Lim D.S., Canman C.E., Kastan M.B. Substrate specificities and identification of putative substrates of ATM kinase family members. J. Biol. Chem. 274:1999;37538-37543.
165. Canman C.E., Lim D.S., Cimprich K.A., Taya Y., Tamai K., Sakaguchi K., Appella E., Kastan M.B., Siliciano J.D. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science. 281:1998;1677-1679.
166. Khanna K.K., Keating K.E., Kozlov S., Scott S., Gatei M., Hobson K., Taya Y., Gabrielli B., Chan D., Lees-Miller S.P., Lavin M.F. ATM associates with and phosphorylates p53: mapping the region of interaction. Nat. Genet. 20:1998;398-400.
167. Chehab N.H., Malikzay A., Stavridi E.S., Halazonetis T.D. Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage. Proc. Natl. Acad. Sci. U.S.A. 96:1999;13777-13782.
168. Nakagawa K., Taya Y., Tamai K., Yamaizumi M. Requirement of ATM in phosphorylation of the human p53 protein at serine 15 following DNA double-strand breaks. Mol. Cell. Biol. 19:1999;2828-2834.
169. Shafman T., Khanna K.K., Kedar P., Spring K., Kozlov S., Yen T., Hobson K., Gatei M., Zhang N., Watters D., Egerton M., Shiloh Y., Kharbanda S., Kufe D., Lavin M.F. Interaction between ATM protein and c-Abl in response to DNA damage. Nature. 387:1997;520-523.
170. Baskaran R., Wood L.D., Whitaker L.L., Canman C.E., Morgan S.E., Xu Y., Barlow C., Baltimore D., Wynshaw-Boris A., Kastan M.B., Wang J.Y. Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation. Nature. 387:1997;516-519.
171. Lim D.S., Kim S.T., Xu B., Maser R.S., Lin J., Petrini J.H., Kastan M.B. ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway. Nature. 404:2000;613-617.
172. Zhao S., Weng Y.C., Yuan S.S., Lin Y.T., Hsu H.C., Lin S.C., Gerbino E., Song M.H., Zdzienicka M.Z., Gatti R.A., Shay J.W., Ziv Y., Shiloh Y., Lee E.Y. Functional link between ataxia-telangiectasia and Nijmegen breakage syndrome gene products. Nature. 405:2000;473-477.
173. Wu X., Ranganathan V., Weisman D.S., Heine W.F., Ciccone D.N., O'Neill T.B., Crick K.E., Pierce K.A., Lane W.S., Rathbun G., Livingston D.M., Weaver D.T. ATM phosphorylation of Nijmegen breakage syndrome protein is required in a DNA damage response. Nature. 405:2000;477-482.
174. Gatei M., Young D., Cerosaletti K.M., Desai-Mehta A., Spring K., Kozlov S., Lavin M.F., Gatti R.A., Concannon P., Khanna K. ATM-dependent phosphorylation of nibrin in response to radiation exposure. Nat. Genet. 25:2000;115-119.
175. Brown A.L., Lee C.H., Schwarz J.K., Mitiku N., Piwnica-Worms H., Chung J.H. A human Cds1-related kinase that functions downstream of ATM protein in the cellular response to DNA damage. Proc. Natl. Acad. Sci. U.S.A. 96:1999;3745-3750.
176. Chaturvedi P., Eng W.K., Zhu Y., Mattern M.R., Mishra R., Hurle M.R., Zhang X., Annan R.S., Lu Q., Faucette L.F., Scott G.F., Li X., Carr S.A., Johnson R.K., Winkler J.D., Zhou B.B. Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway. Oncogene. 18:1999;4047-4054.
177. Matsuoka S., Rotman G., Ogawa A., Shiloh Y., Tamai K., Elledge S.J. Ataxia telangiectasia-mutated phosphorylates chk2 in vivo and in vitro. Proc. Natl. Acad. Sci. U.S.A. 97:2000;10389-10394.
178. Gately D.P., Hittle J.C., Chan G.K., Yen T.J. Characterization of ATM expression, localization, and associated DNA-dependent protein kinase activity. Mol. Biol. Cell. 9:1998;2361-2374.
179. Scully R., Chen J., Ochs R.L., Keegan K., Hoekstra M., Feunteun J., Livingston D.M. Dynamic changes in BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell. 90:1997;425-435.
180. Li S., Ting N.S., Zheng L., Chen P.L., Ziv Y., Shiloh Y., Lee E.Y., Lee W.H. Functional link of BRCA1 and ataxia telangiectasia gene product in DNA damage response. Nature. 406:2000;210-215.
181. Petrini J.H. The Mre11 complex and ATM: collaborating to navigate S phase. Curr. Opin. Cell Biol. 12:2000;293-296.
182. Waterman M.J., Stavridi E.S., Waterman J.L., Halazonetis T.D. ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins. Nat. Genet. 19:1998;175-178.
183. Lane D.P. Cancer p53, guardian of the genome. Nature. 358:1992;15-16.
184. Tsang N.M., Nagasawa H., Li C., Little J.B. Abrogation of p53 function by transfection of HPV16 E6 gene enhances the resistance of human diploid fibroblasts to ionizing radiation. Oncogene. 10:1995;2403-2408.
185. Linke S.P., Clarkin K.C., Wahl G.M. p53 mediates permanent arrest over multiple cell cycles in response to gamma-irradiation. Cancer Res. 57:1997;1171-1179.
186. Huang H., Li C.Y., Little J.B. Abrogation of p53 function by transfection of HPV16 E6 gene does not enhance resistance of human tumour cells to ionizing radiation. Int. J. Radiat. Biol. 70:1996;151-160.
187. Nagasawa H., Li C.Y., Maki C.G., Imrich A.C., Little J.B. Relationship between radiation-induced G1 phase arrest and p53 function in human tumor cells. Cancer Res. 55:1995;1842-1846.
188. Takao N., Kato H., Mori R., Morrison C., Sonada E., Sun X., Shimizu H., Yoshioka K., Takeda S., Yamamoto K. Disruption of ATM in p53-null cells causes multiple functional abnormalities in cellular response to ionizing radiation. Oncogene. 18:1999;7002-7009.
189. Bentley N.J., Holtzman D.A., Flaggs G., Keegan K.S., DeMaggio A., Ford J.C., Hoekstra M., Carr A.M. The Schizosaccharomyces pombe rad3 checkpoint gene. EMBO J. 15:1996;6641-6651.
190. Wright J.A., Keegan K.S., Herendeen D.R., Bentley N.J., Carr A.M., Hoekstra M.F., Concannon P. Protein kinase mutants of human ATR increase sensitivity to UV and ionizing radiation and abrogate cell cycle checkpoint control. Proc. Natl. Acad. Sci. U.S.A. 95:1998;7445-7450.
191. Cliby W.A., Roberts C.J., Cimprich K.A., Stringer C.M., Lamb J.R., Schreiber S.L., Friend S.H. Overexpression of a kinase-inactive ATR protein causes sensitivity to DNA-damaging agents and defects in cell cycle checkpoints. EMBO J. 17:1998;159-169.
192. Hall-Jackson C.A., Cross D.A., Morrice N., Smythe C. ATR is a caffeine-sensitive, DNA-activated protein kinase with a substrate specificity distinct from DNA-PK. Oncogene. 18:1999;6707-6713.
193. Tibbetts R.S., Brumbaugh K.M., Williams J.M., Sarkaria J.N., Cliby W.A., Shieh S.Y., Taya Y., Prives C., Abraham R.T. A role for ATR in the DNA damage-induced phosphorylation of p53. Genes Devlop. 13:1999;152-157.
194. Brown E.J., Baltimore D. ATR disruption leads to chromosomal fragmentation and early embryonic lethality. Genes Devlop. 14:2000;397-402.
195. Chen G., Yuan S.S., Liu W., Xu Y., Trujillo K., Song B., Cong F., Goff S.P., Wu Y., Arlinghaus R., Baltimore D., Gasser P.J., Park M.S., Sung P., Lee E.Y. Radiation-induced assembly of Rad51 and Rad52 recombination complex requires ATM and c-Abl. J. Biol. Chem. 274:1999;12748-12752.
196. Takao N., Mori R., Kato H., Shinohara A., Yamamoto K.I. c-Abl tyrosine kinase is not essential for ataxia telangiectasia mutated functions in chromosomal maintenance. J. Biol. Chem. 275:2000;725-728.
197. Kharbanda S., Yuan Z.M., Weichselbaum R., Kufe D. Determination of cell fate by c-Abl activation in the response to DNA damage. Oncogene. 17:1998;3309-3318.
198. Agami R., Blandino G., Oren M., Shaul Y. Interaction of c-Abl and p73alpha and their collaboration to induce apoptosis. Nature. 399:1999;809-813.
199. Gong J.G., Costanzo A., Yang H.Q., Melino G., Kaelin W.G. Jr., Levrero M., Wang J.Y. The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage. Nature. 399:1999;806-809.
200. Willers H., McCarthy E.E., Wu B., Wunsch H., Tang W., Taghian D.G., Xia F., Powell S.N. Dissociation of p53-mediated suppression of homologous recombination from G1/S cell cycle checkpoint control. Oncogene. 19:2000;632-639.
201. Saintigny Y., Rouillard D., Chaput B., Soussi T., Lopez B.S. Mutant p53 proteins stimulate spontaneous and radiation-induced intrachromosomal homologous recombination independently of the alteration of the transactivation activity and of the G1 checkpoint. Oncogene. 18:1999;3553-3563.
202. Dudenhoffer C., Kurth M., Janus F., Deppert W., Wiesmuller L. Dissociation of the recombination control and the sequence-specific transactivation function of p53. Oncogene. 18:1999;5773-5784.
203. Katagiri T., Saito H., Shinohara A., Ogawa H., Kamada N., Nakamura Y., Miki Y. Multiple possible sites of BRCA2 interacting with DNA repair protein RAD51. Genes Chromosomes Cancer. 21:1998;217-222.
204. Sharan S.K., Morimatsu M., Albrecht U., Lim D.S., Regel E., Dinh C., Sands A., Eichele G., Hasty P., Bradley A. Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature. 386:1997;804-810.
205. Chen P.L., Chen C.F., Chen Y., Xiao J., Sharp Z.D., Lee W.H. The BRC repeats in BRCA2 are critical for RAD51 binding and resistance to methyl methanesulfonate treatment. Proc. Natl. Acad. Sci. U.S.A. 95:1998;5287-5292.
206. Gonzalez R., Silva J.M., Dominguez G., Garcia J.M., Martinez G., Vargas J., Provencio M., Espana P., Bonilla F. Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations. Br. J. Cancer. 81:1999;503-509.
207. Spirin K.S., Simpson J.F., Takeuchi S., Kawamata N., Miller C.W., Koeffler H.P. p27/Kip1 mutation found in breast cancer. Cancer Res. 56:1996;2400-2404.
208. Rasio D., Murakumo Y., Robbins D., Roth T., Silver A., Negrini M., Schmidt C., Burczak J., Fishel R., Croce C.M. Characterization of the human homologue of RAD54: a gene located on chromosome 1p32 at a region of high loss of heterozygosity in breast tumors. Cancer Res. 57:1997;2378-2383.
209. Schmutte C., Tombline G., Rhiem K., Sadoff M.M., Schmutzler R., von Deimling A., Fishel R. Characterization of the human Rad51 genomic locus and examination of tumors with 15q14-15 loss of heterozygosity (LOH). Cancer Res. 59:1999;4564-4569.
210. Kato M., Yano K., Matsuo F., Saito H., Katagiri T., Kurumizaka H., Yoshimoto M., Kasumi F., Akiyama F., Sakamoto G., Nagawa H., Nakamura Y., Miki Y. Identification of Rad51 alteration in patients with bilateral breast cancer. J. Hum. Genet. 45:2000;133-137.
211. Bell D.W., Wahrer D.C., Kang D.H., MacMahon M.S., FitzGerald M.G., Ishioka C., Isselbacher K.J., Krainer M., Haber D.A. Common nonsense mutations in RAD52. Cancer Res. 59:1999;3883-3888.
212. Matsuda M., Miyagawa K., Takahashi M., Fukuda T., Kataoka T., Asahara T., Inui H., Watatani M., Yasutomi M., Kamada N., Dohi K., Kamiya K. Mutations in the RAD54 recombination gene in primary cancers. Oncogene. 18:1999;3427-3430.
213. Ingraham S.E., Lynch R.A., Kathiresan S., Buckler A.J., Menon A.G. hREC2, a RAD51-like gene is disrupted by t(12; 14) (q15; q24.1) in a uterine leiomyoma. Cancer Genet. Cytogenet. 115:1999;56-61.
214. Schoenmakers E.F., Huysmans C., Van de Ven W.J. Allelic knockout of novel splice variants of human recombination repair gene RAD51B in t(12; 14) uterine leiomyomas. Cancer Res. 59:1999;19-23.
215. El-Rifai W., Sarlomo-Rikala M., Andersson L.C., Miettinen M., Knuutila S. High-resolution deletion mapping of chromosome 14 in stromal tumors of the gastrointestinal tract suggests two distinct tumor suppresser loci. Genes Chromosomes. 27:2000;387-391.
216. Bjorkqvist A.M., Wolf M., Nordling S., Tammilehto L., Knuuttila A., Kere J., Mattson K., Knuutila S. Deletions at 14q in malignant mesothelioma detected by microsatellite marker analysis. Br. J. Cancer. 81:1999;1111-1115.
217. Theobald M., Christiansen H., Schmidt A., Melekian B., Wolkewitz N., Christiansen N.M., Brinkschmidt C., Berthold F., Lampert F. Sublocalization of putative tumor suppresser gene loci on chromosome arm 14q in neuroblastoma. Genes Chromosomes Cancer. 26:1999;40-46.
218. Bando T., Kato Y., Ihara Y., Yamagishi F., Tsukada K., Isobe M. Loss of heterozygosity of 14q32 in colorectal carcinoma. Cancer Genet. Cytogenet. 111:1999;161-165.
219. Mutirangura A., Pornthanakasem W., Sriuranpong V., Supiyaphun P., Voravud N. Loss of heterozygosity on chromosome 14 in nasopharyngeal carcinoma. Int. J. Cancer. 78:1998;153-156.
220. Parshad R., Gantt R., Sanford K.K., Jones G.M. Chromosomal radiosensitivity of human tumor cells during the G2 cell cycle period. Cancer Res. 44:1984;5577-5582.
221. Darroudi F., Vyas R.C., Vermeulen S., Natarajan A.T. G2 radiosensitivity of cells derived from cancer-prone individuals. Mutat. Res. 328:1995;83-90.
222. Suganuma M., Kawabe T., Hori H., Funabiki T., Okamoto T. Sensitization of cancer cells to DNA damage-induced cell death by specific cell cycle G2 checkpoint abrogation. Cancer Res. 59:1999;5887-5891.
223. Jackson J.R., Gilmartin A., Imburgia C., Winkler J.D., Marshall L.A., Roshak A. An indolocarbazole inhibitor of human checkpoint kinase (Chk1) abrogates cell cycle arrest caused by DNA damage. Cancer Res. 60:2000;566-572.
224. Graves P.R., Yu L., Schwarz J.K., Gales J., Sausville E.A., O'Connor P.M., Piwnica-Worms H. The chk1 protein kinase and the Cdc25C regulatory pathways are targets of the anticancer agent UCN-01. J. Biol. Chem. 275:2000;5600-5605.
225. Deans B., Griffin C.S., Maconochie M., Thacker J. Xrcc2 is required for genetic stability, embryonic neurogenesis and viability in mice. EMBO J. 19:2000;6675-6685.
226. Volkmer E., Karnitz L.M. Human homologs of Schizosaccharomyces pombe Rad1, Hus1, and Rad9 form a DNA damage-responsive protein complex. J. Biol. Chem. 274:1999;567-570.
227. Milner J., Ponder B., Hughes-Davies L., Seltmann M., Kouzarides T. Transcriptional activation functions in BRCA2. Nature. 386:1997;772-773.
228. Chen Y., Lee W.H., Chew H.K. Emerging roles of BRCA1 in transcriptional regulation and DNA repair. J. Cell. Physiol. 181:1999;385-392.
229. Marmorstein L.Y., Ouchi T., Aaronson S.A. The Brca2 gene product functionally interacts with p53 and RAD51. Proc. Natl. Acad. Sci. U.S.A. 95:1998;13869-13874.
230. Ouchi T., Monteiro A.N., August A., Aaronson S.A., Hanafusa H. BRCA1 regulates p53-dependent gene expression. Proc. Natl. Acad. Sci. U.S.A. 95:1998;2302-2306.
231. Somasundaram K., Zhang H., Zeng Y.X., Houvras Y., Peng Y., Zhang H., Wu G.S., Licht J.D., Weber B.L., El-Deiry W.S. Arrest of the cell cycle by the tumour-suppresser BRCA1 requires the CDK-inhibitor p21WAF1/CiP1. Nature. 389:1997;187-190.
232. Zhang H., Somasundaram K., Peng Y., Tian H., Zhang H., Bi D., Weber B.L., El-Deiry W.S. BRCA1 physically associates with p53 and stimulates its transcriptional activity. Oncogene. 16:1998;1713-1721.
233. Bunz F., Dutriaux A., Lengauer C., Waldman T., Zhou S., Brown J.P., Sedivy J.M., Kinzler K.W., Vogelstein B. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science. 282:1998;1497-1501.
234. Waldman T., Kinzler K.W., Vogelstein B. p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res. 55:1995;5187-5190.
235. Deng C., Zhang P., Harper J.W., Elledge S.J., Leder P. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell. 82:1995;675-684.
236. Brugarolas J., Chandrasekaran C., Gordon J.I., Beach D., Jacks T., Hannon G.J. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature. 377:1995;552-557.
237. Sanchez Y., Wong C., Thoma R.S., Richman R., Wu Z., Piwnica-Worms H., Elledge S.J. Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25. Science. 277:1997;1497-1501.
238. Shieh S.Y., Ahn J., Tamai K., Taya Y., Prives C. The human homologs of checkpoint kinases chk1 and cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites. Genes Devlop. 14:2000;289-300.
239. Chehab N.H., Malikzay A., Appel M., Halazonetis T.D. Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53. Genes Devlop. 14:2000;278-288.
240. Hirao A., Kong Y.Y., Matsuoka S., Wakeham A., Ruland J., Yoshida H., Liu D., Elledge S.J., Mak T.W. DNA damage-induced activation of p53 by the checkpoint kinase Chk2. Science. 287:2000;1824-1827.
241. Li W., Hesabi B., Babbo A., Pacione C., Liu J., Chen D.J., Nickoloff J.A., Shen Z. Regulation of double-strand break-induced mammalian homologous recombination by UBL1, a RAD51-interacting protein. Nucl. Acids Res. 28:2000;1145-1153.